✦ LIBER ✦

SP025 Genotype-based combinations of RAS/RAF and PI3K pathway inhibitors

✍ Scribed by Banerji, U.

Book ID: 122233010
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 49 KB
Volume: 49
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(13)70103-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Defining optimal combinations of PI3K/Ak

Defining optimal combinations of PI3K/Akt/mTOR and Ras/Raf/MAPK pathway inhibitors for use in endometrial cancer

✍ Isani, S.S.; Rodriguez-Gabin, A.G.; Goldberg, G.L.; Horwitz, S.B.; McDaid, H.M. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 147 KB

323 POSTER Dependence on PI3K and RAS–RA

323 POSTER Dependence on PI3K and RAS–RAF pathways drives the activity of the combination of RAD001 and RAF265, a novel inhibitor of the RAF-MAPK pathway

✍ P. Mordant; C. Leteur; J. Bourhis; J.C. Soria; E. Deutsch 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 55 KB

253 Screening for PIK3CA, RAS, and RAF m

253 Screening for PIK3CA, RAS, and RAF mutations in trials with PI3K/AKT/mTOR signaling pathway inhibitors

✍ F. Janku; A.M. Tsimberidou; I. Garrido-Laguna; D.S. Hong; A.M. Naing; G.S. Falch 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Protein and lipid kinase inhibitors as t

Protein and lipid kinase inhibitors as targeted anticancer agents of the Ras/Raf/MEK and PI3K/PKB pathways

✍ Carlos García-Echeverría 📂 Article 📅 2008 🏛 Springer Netherlands 🌐 English ⚖ 197 KB

SP 114 Predictive and pharmacodynamic (P

SP 114 Predictive and pharmacodynamic (PD) markers of PI3K pathway inhibitors: focus on PI3K, AKT and mTOR inhibitors

✍ J. Tabernero 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Pathway crosstalk between Ras/Raf and PI

Pathway crosstalk between Ras/Raf and PI3K in promotion of M-CSF-induced MEK/ERK-mediated osteoclast survival

✍ Elizabeth W. Bradley; Ming M. Ruan; Anne Vrable; Merry Jo Oursler 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 539 KB

## Abstract While M‐CSF‐mediated MEK/ERK activation promotes osteoclast survival, the signaling pathway by which M‐CSF activates MEK/ERK is unresolved. Functions for PI3K, Ras, and Raf have been implicated in support of osteoclast survival, although interaction between these signaling components ha